Jennifer Wu

814 total citations
39 papers, 579 citations indexed

About

Jennifer Wu is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jennifer Wu has authored 39 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 13 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jennifer Wu's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immunotherapy and Immune Responses (5 papers). Jennifer Wu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immunotherapy and Immune Responses (5 papers). Jennifer Wu collaborates with scholars based in United States, United Kingdom and Japan. Jennifer Wu's co-authors include Andrew X. Zhu, Jennifer Ng, Patrick M. Boland, Franco M. Muggia, Songchuan Guo, George Miller, Lawrence Leichman, Howard S. Höchster, Bin Zhang and Bert H. O’Neil and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jennifer Wu

36 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Wu United States 12 206 186 181 127 115 39 579
Jianyong Zhuo China 14 280 1.4× 157 0.8× 134 0.7× 123 1.0× 160 1.4× 40 637
Miral S. Grandhi United States 8 198 1.0× 163 0.9× 144 0.8× 173 1.4× 110 1.0× 39 544
Yifu He China 16 283 1.4× 92 0.5× 238 1.3× 191 1.5× 131 1.1× 78 717
Yifei Cheng China 12 285 1.4× 91 0.5× 110 0.6× 200 1.6× 101 0.9× 39 566
Wai Meng David Tai Singapore 12 220 1.1× 265 1.4× 280 1.5× 96 0.8× 130 1.1× 33 645
Sedat Karademır Türkiye 16 253 1.2× 137 0.7× 192 1.1× 105 0.8× 84 0.7× 43 731
Dong‐Hao Wu China 13 116 0.6× 172 0.9× 259 1.4× 165 1.3× 192 1.7× 35 548
Federico Piñero Argentina 11 239 1.2× 310 1.7× 131 0.7× 176 1.4× 248 2.2× 38 712
Lois Dickie United States 11 107 0.5× 195 1.0× 234 1.3× 130 1.0× 204 1.8× 14 630
Jason B. Litten United States 9 202 1.0× 102 0.5× 132 0.7× 87 0.7× 47 0.4× 21 537

Countries citing papers authored by Jennifer Wu

Since Specialization
Citations

This map shows the geographic impact of Jennifer Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Wu more than expected).

Fields of papers citing papers by Jennifer Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Wu. The network helps show where Jennifer Wu may publish in the future.

Co-authorship network of co-authors of Jennifer Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Wu. A scholar is included among the top collaborators of Jennifer Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Wu. Jennifer Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sieriebriennikov, Bogdan, Jennifer Wu, Ildar Gainetdinov, et al.. (2025). Transcriptional interferences ensure one olfactory receptor per ant neuron. Nature. 648(8093). 418–426.
2.
Wu, Jennifer, et al.. (2025). Assessing the Application of Physiologically Based Pharmacokinetic Models in Acute Chemical Incidents. Journal of Xenobiotics. 15(2). 42–42.
3.
Abrams, Ross A., Kathryn Winter, Karyn A. Goodman, et al.. (2024). NRG Oncology/RTOG 0848: Results after adjuvant chemotherapy +/- chemoradiation for patients with resected periampullary pancreatic adenocarcinoma (PA).. Journal of Clinical Oncology. 42(16_suppl). 4005–4005. 9 indexed citations
4.
Wu, Jennifer, et al.. (2023). Immunotherapy for recurrent hepatocellular carcinoma. World Journal of Gastroenterology. 29(15). 2261–2271. 10 indexed citations
5.
Wu, Jennifer, et al.. (2023). Role of radiotherapy and its contribution to immunotherapy in hepatocellular carcinoma. Chinese Clinical Oncology. 12(4). 41–41. 4 indexed citations
6.
Silk, Mikhail, et al.. (2022). Up to seven criteria in selection of systemic therapy for hepatocellular carcinoma. World Journal of Gastroenterology. 28(23). 2561–2568. 8 indexed citations
7.
Chen, Mingyu, Jiasheng Cao, Jiahao Hu, et al.. (2021). Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma. Liver Cancer. 10(1). 38–51. 79 indexed citations
8.
Rashid, Tariq, et al.. (2020). Rapid nuclear medicine blood volume analysis for emergency assessment. Journal of Emergencies Trauma and Shock. 13(4). 301–301. 3 indexed citations
9.
Jordan, Alexander C. & Jennifer Wu. (2020). Immunotherapy in hepatocellular carcinoma: Combination strategies. World Journal of Meta-Analysis. 8(3). 190–209. 2 indexed citations
10.
Wu, Jennifer, et al.. (2019). Evaluation of a locked nucleic acid form of antisense oligo targeting HIF-1α in advanced hepatocellular carcinoma. World Journal of Clinical Oncology. 10(3). 149–160. 34 indexed citations
11.
12.
Wu, Jennifer, et al.. (2018). Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 10(5). 108–114. 24 indexed citations
13.
Kwa, Maryann, Xiaochun Li, Yelena Novik, et al.. (2017). Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer. Breast Cancer Research and Treatment. 168(1). 57–67. 18 indexed citations
14.
Guo, Songchuan, et al.. (2017). Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations. World Journal of Clinical Oncology. 8(3). 230–230. 44 indexed citations
15.
Lin, Richard J., Jonathan Melamed, & Jennifer Wu. (2017). PEComa with Transcription Factor E3 Overexpression: A Diagnostic and Therapeutic Challenge. Case Reports in Oncology. 10(2). 531–533. 6 indexed citations
16.
Hagan, Holly, Ashly E. Jordan, Don C. Des Jarlais, et al.. (2014). Hepatitis C virus infection among HIV-positive men who have sex with men: protocol for a systematic review and meta-analysis. Systematic Reviews. 3(1). 31–31. 16 indexed citations
17.
Wu, Jennifer, et al.. (2012). Targeted therapy: its status and promise in selected solid tumors. Part II: Impact on selected tumor subsets, and areas of evolving integration.. PubMed. 26(11). 1021–30, 1035. 8 indexed citations
18.
Ng, Jennifer & Jennifer Wu. (2012). Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences. Hepatitis Monthly. 12(10 HCC). e7635–e7635. 55 indexed citations
19.
Wu, Jennifer & Andrew X. Zhu. (2011). Targeting insulin-like growth factor axis in hepatocellular carcinoma. Journal of Hematology & Oncology. 4(1). 30–30. 92 indexed citations
20.
Pavlick, Anna C., Jennifer Wu, John D. Roberts, et al.. (2009). Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors. Cancer Chemotherapy and Pharmacology. 64(4). 803–810. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianyong Zhuo Breakdown of academic impact, for papers by Miral S. Grandhi Breakdown of academic impact, for papers by Yifu He Breakdown of academic impact, for papers by Yifei Cheng Breakdown of academic impact, for papers by Wai Meng David Tai Breakdown of academic impact, for papers by Sedat Karademır Breakdown of academic impact, for papers by Dong‐Hao Wu Breakdown of academic impact, for papers by Federico Piñero Breakdown of academic impact, for papers by Lois Dickie Breakdown of academic impact, for papers by Jason B. Litten
Rankless by CCL
2026